Adcendo ApS is a Copenhagen-based biotech company dedicated to developing antibody-drug conjugates (ADCs) for treatment of cancer. We are taking the ADC approach to new levels through a focus on cancer-associated targets that are professional internalizers and allow for superior selectivity via highly preferential cancer expression.
Adcendo has been part of BioInnovation Institute’s Creation House Program from mid 2019 unti...
Adcendo ApS is a Copenhagen-based biotech company dedicated to developing antibody-drug conjugates (ADCs) for treatment of cancer. We are taking the ADC approach to new levels through a focus on cancer-associated targets that are professional internalizers and allow for superior selectivity via highly preferential cancer expression.
Adcendo has been part of BioInnovation Institute’s Creation House Program from mid 2019 until closing of series A financing in April 2021.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.